There are 2949 resources available
Welcome and Introduction
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Expert insights: Adapting treatment during the COVID-19 pandemic
Presenter: Pippa Corrie
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Emerging long-term survival data and implications for clinical practice
Presenter: Pippa Corrie
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Studying survival: An evidence-based approach to improving outcomes
Presenter: Paolo Ascierto
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Live Q&A - 23 September 2020 - 11:30-12:00
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
12P - Genome mining-aided biosynthesis overcomes Temozolomide-resistant glioblastoma via negatively regulating cIAP-mediated degradation of PACS2 and ER-mitochondria contact sites
Presenter: Lei Chen
Session: E-Poster Display
Resources:
Abstract
13P - Synergistic activity of PARP inhibitor and ATR inhibitor in melanoma cell lines may depend on BRAF-V600 mutation status
Presenter: Emilio Giunta
Session: E-Poster Display
Resources:
Abstract
10P - Targeting Angiomotin-p130 reverse resistance to antiangiogenic therapies in breast cancer by inhibition of vasculogenic mimicry
Presenter: Yanwei Shen
Session: E-Poster Display
Resources:
Abstract
11P - Preclinical evaluation of DS-2087b, a novel and selective inhibitor of EGFR/HER2 exon 20 insertions
Presenter: Yasuhito Nagamoto
Session: E-Poster Display
Resources:
Abstract
14P - Modulation of MCF-7 cell sensitivity to anticancer agents by targeting glycolysis
Presenter: Alexander Scherbakov
Session: E-Poster Display
Resources:
Abstract